Latest news

Hide mandatory notifications of trade

Approved prospectus and details regarding subsequent offering

Oslo 8.10.2013 - Reference is made to the stock exchange announcements made by Bionor Pharma ASA (the "Company") dated 12 September 2013 and 13 September 2013 regarding (i) a private placement (the "Private Placement") of 19,800,000 new shares in the Company (the "New Shares"), and (ii) the subsequent offering (the "Subsequent Offering") of up to 7,500,000 additional shares in the Company (the "Offer Shares").

At the extraordinary general meeting held on 7 October 2013, the Board of Directors was granted an authorization to increase the share capital by up to NOK 1,875,000 for the purpose of completing an offering with allocation preference to shareholders who were not allocated shares in the private placement completed on 12 September 2013. The Subsequent Offering will be directed towards existing shareholders as of 12 September 2013, as registered in the VPS on 17 September 2013 (the "Record Date"), who were not allocated shares in the Private Placement and who are not resident in a jurisdiction where such offering would be unlawful, or for jurisdictions other than Norway, would require any filing, registration or similar action, (the "Eligible Shareholders"). Eligible Shareholders have been granted 1 non-transferable Allocation Rights for each 15.628227 existing shares registered as of the Record Date rounded down to the nearest whole subscription right. The Allocation Rights, subject to applicable laws, provide rights to subscribe for and be allocated Offer Shares in the Offering. Over-subscription and subscription without Allocation Rights will be permitted. Allocation rights not used to subscribe for Offer Shares before the end of the subscription period will lapse without compensation to the holder, and consequently be of no value.

The subscription period for the Subsequent Offering commences 8 October 2013 and expires at 16:30 hours (CET) on 22 October 2013. The subscription price per Offer Share is NOK 2.75, equal to the subscription price in the Private Placement. The number of allocation rights can be viewed on the shareholders’ VPS accounts on or about 8 October 2013. The subscription rights can be exercised by duly completing and delivering the subscription form, in accordance with the terms and conditions set out in the Prospectus, to the following subscription office:

Skandinaviska Enskilda banken AB (publ) Oslo branch
Filipstad Brygge 1
P.O. Box 1843 Vika
0123 Oslo
Tel: +47 22 82 70 00
Fax: +47 21 00 89 05

Norwegian residents with a Norwegian personal identification number can subscribe online by accessing the url link. Click here.

Following the expiry of the subscription period, the subscribers who have subscribed for shares will be notified how many shares they have been allocated. By executing the application form, each applicant grants a one-time authorization for the managers to debit the applicant’s bank account for the total amount due for the allocated shares. Payment date is expected on or about 28 October 2013. The full amount for the allocated shares must be available on the specified bank account on 25 October 2013.

Any questions or requests for assistance concerning the Subsequent Offering should be directed to the subscription office mentioned above.

SEB is acting as sole manager for the Private Placement and the Subsequent Offering.

For further information about the Subsequent Offering, reference is made to the Prospectus. Link to the Prospectus, click here